http://ift.tt/eA8V8J New research indicates that the live varicella-zoster vaccine -- which is given to protect against shingles -- elicits robust immune responses in patients when administered several weeks prior to the start of treatment with the arthritis drug tofacitinib.
from Latest Science News -- ScienceDaily http://ift.tt/2gjqfTR
via IFTTT
No comments:
Post a Comment